{"entity":{"id":"nct05865028","kind":"trial","name":"A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia","aka":[],"tldr":"A phase 2 trial of APG-157 run by Elizabeth J Franzmann, now recruiting.","summary":"A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia is a phase 2 interventional study registered as NCT05865028 by Elizabeth J Franzmann, with 32 participants planned, started 2023-05-24. Conditions recorded: Oropharyngeal Dysplasia, Oral Cavity Dysplasia and Oral Carcinoma in Situ. Interventions recorded: APG-157.","status":"recruiting","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT05865028","url":"https://clinicaltrials.gov/study/NCT05865028"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["oropharyngeal-cancer","oral-cavity-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["apg-157"],"companies":["aveta-biomics"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05865028","phase":"2","setting":"Phase II A Proof of Concept Trial Investigating Safety and Efficacy of APG-157 in Oral Dysplasia","sponsor":"Elizabeth J Franzmann","enrolled":32,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05865028/","neighbours":{"cancer":[{"id":"oral-cavity-cancer","kind":"cancer","name":"Oral cavity cancer (mouth and tongue)","route":"/cancers/oral-cavity-cancer/"},{"id":"oropharyngeal-cancer","kind":"cancer","name":"Oropharyngeal cancer (tonsil and base of tongue)","route":"/cancers/oropharyngeal-cancer/"}],"drug":[{"id":"apg-157","kind":"drug","name":"APG-157","route":"/drugs/apg-157/"}],"company":[{"id":"aveta-biomics","kind":"company","name":"Aveta Biomics","route":"/companies/aveta-biomics/"}]}}